Entity Details

Primary name RASK_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP01116
EntryNameRASK_HUMAN
FullNameGTPase KRas
TaxID9606
Evidenceevidence at protein level
Length189
SequenceStatuscomplete
DateCreated1986-07-21
DateModified2021-06-02

Ontological Relatives

GenesKRAS

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0000165 MAPK cascade
GO:0001889 liver development
GO:0001934 positive regulation of protein phosphorylation
GO:0002223 stimulatory C-type lectin receptor signaling pathway
GO:0003924 GTPase activity
GO:0003925 G protein activity
GO:0005525 GTP binding
GO:0005737 cytoplasm
GO:0005741 mitochondrial outer membrane
GO:0005789 endoplasmic reticulum membrane
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0005925 focal adhesion
GO:0007265 Ras protein signal transduction
GO:0007565 female pregnancy
GO:0008284 positive regulation of cell population proliferation
GO:0008542 visual learning
GO:0010628 positive regulation of gene expression
GO:0016020 membrane
GO:0019002 GMP binding
GO:0019003 GDP binding
GO:0019221 cytokine-mediated signaling pathway
GO:0021897 forebrain astrocyte development
GO:0030036 actin cytoskeleton organization
GO:0030275 LRR domain binding
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane
GO:0031647 regulation of protein stability
GO:0032228 regulation of synaptic transmission, GABAergic
GO:0035022 positive regulation of Rac protein signal transduction
GO:0035900 response to isolation stress
GO:0038002 endocrine signaling
GO:0042802 identical protein binding
GO:0043406 positive regulation of MAP kinase activity
GO:0043524 negative regulation of neuron apoptotic process
GO:0044877 protein-containing complex binding
GO:0045121 membrane raft
GO:0045596 negative regulation of cell differentiation
GO:0048169 regulation of long-term neuronal synaptic plasticity
GO:0048873 homeostasis of number of cells within a tissue
GO:0051000 positive regulation of nitric-oxide synthase activity
GO:0051092 positive regulation of NF-kappaB transcription factor activity
GO:0051146 striated muscle cell differentiation
GO:0051384 response to glucocorticoid
GO:0051385 response to mineralocorticoid
GO:0060441 epithelial tube branching involved in lung morphogenesis
GO:2000774 positive regulation of cellular senescence

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR001806 Small GTPaseFamilyFamily
IPR005225 Small GTP-binding protein domainDomainDomain
IPR020849 Small GTPase, Ras-typeFamilyFamily
IPR027417 P-loop containing nucleoside triphosphate hydrolaseFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615278 OMIMCardiofaciocutaneous syndrome 2 (CFC2)A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1. The disease is caused by variants affecting the gene represented in this entry.
607785 OMIMLeukemia, juvenile myelomonocytic (JMML)An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. The disease is caused by variants affecting the gene represented in this entry.
613659 OMIMGastric cancer (GASC)A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. The disease is caused by variants affecting the gene represented in this entry.
600268 OMIMOculoectodermal syndrome (OES)A syndrome characterized by the association of epibulbar dermoids and aplasia cutis congenita. Affected individuals show multiple, asymmetric, atrophic, non-scarring and hairless regions that may be associated with hamartomas. Ectodermal changes include linear hyperpigmentation that may follow the lines of Blaschko and rarely epidermal nevus-like lesions. Epibulbar dermoids may be uni-or bilateral. Additional ocular anomalies such as skin tags of the upper eyelid, rarely optic nerve or retinal changes, and microphthalmia can be present. The phenotypic expression is highly variable, and various other abnormalities have occasionally been reported including growth failure, lymphedema, cardiovascular defects, as well as neurodevelopmental symptoms like developmental delay, epilepsy, learning difficulties, and behavioral abnormalities. Benign tumor-like lesions such as nonossifying fibromas of the long bones and giant cell granulomas of the jaws have repeatedly been observed and appear to be age-dependent, becoming a common manifestation in individuals aged 5 years or older. The disease is caused by variants affecting the gene represented in this entry.
601626 OMIMLeukemia, acute myelogenous (AML)A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes. The disease is caused by variants affecting the gene represented in this entry.
163200 OMIMSchimmelpenning-Feuerstein-Mims syndrome (SFM)A disease characterized by sebaceous nevi, often on the face, associated with variable ipsilateral abnormalities of the central nervous system, ocular anomalies, and skeletal defects. Many oral manifestations have been reported, not only including hypoplastic and malformed teeth, and mucosal papillomatosis, but also ankyloglossia, hemihyperplastic tongue, intraoral nevus, giant cell granuloma, ameloblastoma, bone cysts, follicular cysts, oligodontia, and odontodysplasia. Sebaceous nevi follow the lines of Blaschko and these can continue as linear intraoral lesions, as in mucosal papillomatosis. The disease is caused by variants affecting the gene represented in this entry.
609942 OMIMNoonan syndrome 3 (NS3)A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB07771 [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACIDDrugbanksmall molecule
DB07780 Farnesyl diphosphateDrugbanksmall molecule
DB15568 MRTX849Drugbanksmall molecule
DB15569 AMG-510Drugbanksmall molecule

Interactions

85 interactions

InteractorPartnerSourcesPublicationsLink
RASK_HUMANHNRPC_HUMANBioGRID, HPRD, IntAct16189514 27684187 details
RASK_HUMANRASF2_HUMANBioGRID, HPRD, UniProt12732644 details
RASK_HUMANRAF1_HUMANBioGRID, DIP, HPRD, I2D, IntAct10783161 10882715 10958680 15192046 16041367 16093354 19029954 20080631 20802526 23153539 25852190 26721396 27684187 28205554 30194290 31980649 34079125 8307946 9446616 9564038 details
RASK_HUMANADH6_HUMANBioGRID, IntAct21988832 details
RASK_HUMANLPAR1_HUMANBioGRID, IntAct21988832 details
RASK_HUMANP85B_HUMANBioGRID, IntAct21988832 34079125 details
RASK_HUMANDDX47_HUMANBioGRID, IntAct21988832 details
RASK_HUMANEGLN1_HUMANBioGRID, IntAct21988832 details
RASK_HUMANDDX50_HUMANBioGRID, IntAct21988832 details
RASK_HUMANRGL2_HUMANBioGRID, IntAct21988832 details
RASK_HUMANGNDS_HUMANBioGRID, HPRD, IntAct10783161 21988832 7809086 details
RASK_HUMANDEAF1_HUMANMINT21900206 details
RASK_HUMANTCPH_HUMANBioGRID, MINT21900206 details
RASK_HUMANEF1A1_HUMANBioGRID, MINT21900206 27684187 details
RASK_HUMANIGS21_HUMANBioGRID, MINT21900206 details
RASK_HUMANMYOME_HUMANBioGRID, MINT21900206 details
RASK_HUMANCDK8_HUMANBioGRID, MINT24412244 details
RASK_HUMANFANCC_HUMANBioGRID, MINT24412244 details
RASK_HUMANFRAT2_HUMANBioGRID, MINT24412244 details
RASK_HUMANHEMGN_HUMANBioGRID, MINT24412244 details
RASK_HUMANIBP3_HUMANBioGRID, MINT24412244 details
RASK_HUMANPP2AB_HUMANBioGRID, MINT24412244 details
RASK_HUMANSTX17_HUMANBioGRID, MINT24412244 details
RASK_HUMANZN189_HUMANBioGRID, MINT24412244 details
RASK_HUMANCYB_HUMANBioGRID, MINT25640309 details
RASK_HUMANMOC2A_HUMANBioGRID, MINT25640309 details
RASK_HUMANCOX3_HUMANBioGRID, MINT25640309 details
RASK_HUMANQCR1_HUMANBioGRID, MINT25640309 details
RASK_HUMANDHPR_HUMANBioGRID, MINT25640309 details
RASK_HUMANTNF13_HUMANBioGRID, MINT25640309 details
RASK_HUMANBCAS3_HUMANBioGRID, MINT25640309 details
RASK_HUMANDIRA3_HUMANBioGRID, MINT25640309 details
RASK_HUMANCCL5_HUMANBioGRID, MINT25640309 details
RASK_HUMANIL24_HUMANBioGRID, MINT25640309 details
RASK_HUMANOSGI1_HUMANBioGRID, MINT25640309 details
RASK_HUMANTHRSP_HUMANBioGRID, MINT25640309 details
RASK_HUMANSPB5_HUMANBioGRID, MINT25640309 details
RASK_HUMANZDH17_HUMANBioGRID, IntAct24705354 details
RASK_HUMANARAF_HUMANBioGRID, IntAct25416956 25852190 28205554 30194290 34079125 details
RASK_HUMANBRAF_HUMANBioGRID, IntAct27034005 27684187 28205554 28514442 30194290 31980649 34079125 details
RASK_HUMANPDE6D_HUMANDIP23698361 details
RASK_HUMANRASK_HUMANBioGRID, DIP26051715 27213482 27684187 30194290 30442766 30639242 details
RASK_HUMANA4_HUMANBioGRID, IntAct21832049 30194290 32814053 details
RASK_HUMANGDS1_HUMANBioGRID, HPRD11948427 20709748 details
RASK_HUMANSHOC2_HUMANBioGRID, HPRD10783161 34079125 9674433 details
RASK_HUMANPK3CA_HUMANBioGRID10783161 34079125 details
RASK_HUMANRASF5_HUMANBioGRID, HPRD11857081 details
RASK_HUMANEPB42_HUMANBioGRID, HPRD3276554 details
RASK_HUMANPK3CG_HUMANBioGRID, HPRD10542052 details
RASK_HUMANRGRF2_HUMANBioGRID11238945 details
RASK_HUMANDNJA3_HUMANBioGRID18624398 details
RASK_HUMANCALM1_HUMANBioGRID, HPRD11585916 12727204 27684187 details
RASK_HUMANCALM2_HUMANBioGRID, HPRD11585916 12727204 27684187 details
RASK_HUMANCALM3_HUMANBioGRID, HPRD11585916 12727204 27684187 details
RASK_HUMANMDFI_HUMANBioGRID25416956 details
RASK_HUMANPSA3_HUMANBioGRID25416956 details
RASK_HUMANRBPMS_HUMANBioGRID25416956 details
RASK_HUMANMOC2B_HUMANBioGRID25640309 details
RASK_HUMANPRAF3_HUMANBioGRID27229929 30194290 details
RASK_HUMANLYPD4_HUMANBioGRID27229929 details
RASK_HUMANNDUAD_HUMANBioGRID27229929 details
RASK_HUMANRHOA_HUMANBioGRID27229929 30194290 details
RASK_HUMANLZTR1_HUMANBioGRID30194290 30442762 30442766 30872527 31337872 34079125 details
RASK_HUMANRASH_HUMANBioGRID30194290 30442766 30655611 details
RASK_HUMANMTOR_HUMANBioGRID30639242 34079125 details
RASK_HUMANPI51A_HUMANBioGRID30194290 34079125 details
RASK_HUMANWDR76_HUMANBioGRID30655611 details
RASK_HUMANSOX4_HUMANBioGRID28205554 details
RASK_HUMANGRB7_HUMANIntAct29290818 details
RASK_HUMANSOS2_HUMANIntAct29290818 details
RASK_HUMANPHB_HUMANBioGRID16041367 details
RASK_HUMANMK01_HUMANBioGRID10958680 details
RASK_HUMANFBW1A_HUMANBioGRID24709419 details
RASK_HUMANBCL2_HUMANBioGRID, HPRD10490827 19433448 details
RASK_HUMANTRAF6_HUMANBioGRID24026882 details
RASK_HUMANNIBA2_HUMANBioGRID26721396 30442766 30639242 34079125 details
RASK_HUMANSPSB1_HUMANBioGRID29534718 details
RASK_HUMANRAGE_HUMANBioGRID25341034 details
RASK_HUMANRICTR_HUMANBioGRID30442766 30639242 34079125 details
RASK_HUMANEGFR_HUMANBioGRID12783862 30194290 30639242 34079125 details
RASK_HUMANSIN1_HUMANBioGRID30639242 34079125 details
RASK_HUMANCUL3_HUMANBioGRID31337872 details
RASK_HUMANPGTB1_HUMANHPRD15451670 details
RASK_HUMANFNTA_HUMANHPRD12374986 details
RASK_HUMANFNTB_HUMANHPRD12374986 details